The breakthrough by Nagasaki University's Institute of Tropical Medicine will allow medics to move much more quickly in treating people with the hemorrhagic fever, Professor Jiro Yasuda told AFP.
"The result time was unexpectedly short," said Yasuda of the trial conducted in Guinea last month on 100 samples, of which 47 proved positive.
Also Read
The test hinges on what the researchers have called a "primer", a substance that amplifies only those genes specific to the Ebola virus found in a blood sample or other bodily fluid.
Using existing techniques, ribonucleic acid (RNA) -- biological molecules used in the coding of genes is extracted from any viruses present in a sample.
This is then used to synthesise the viral DNA, which can be mixed with the primer and then heated to 60-65 degrees Celsius (140-149 Fahrenheit).
If Ebola is present, DNA specific to the virus is amplified by the action of the primers. The by-products from the process cause the liquid to become cloudy, providing visual confirmation, Yasuda said.
Currently, a method called polymerase chain reaction, or PCR, is used to detect the Ebola virus. This requires doctors to heat and cool samples repeatedly and takes at least 90 minutes, sometimes up to two hours.
The Ebola virus, transmitted through contact with infected bodily fluids, has killed more than 10,000 people in western Africa since it re-emerged in December 2013.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)